These microarray signatures lead to the stratification of breast cancer patients based on their level of expression of estrogen receptor alpha (ERα), progesterone receptor (PR), or the human epidermal growth factor receptor 2; ERBB2 (HER2) [2,3]. The gene discussed is ERBB2; the disease is breast cancer.